2022美国妇科泌尿学会(AUGS)/国际妇科泌尿协会(IUGA)联合科学会议

AUGS/IUGA Scientific Meeting 2022
Date: June 14–18, 2022
Venue: Austin Convention Center, Austin, Texas, USA + VIRTUAL

The American Urogynecologic Society (AUGS) and International Urogynecological Association (IUGA) 2022 Scientific Meeting will serve as the year’s largest venue for those in the field of urogynecology and Female Pelvic Medicine and Reconstructive Surgery to come together for education, networking and sharing.

摘要征集：

• Abstract submission form available online: October 15, 2021
• Deadline abstract submission: January 31, 2022 (will not be extended)
• Accept/Reject Notifications: Beginning of March
  

Submit an Abstract

Abstract Submission Guidelines

Who Is Eligible to Submit?
IUGA Members, AUGS Members and non-members are eligible to submit an abstract.

Eligibility
Work submitted for presentation at this meeting may not have been previously published or presented at another international meeting (for example ICS). Please do not submit case reports as they are not permitted and will not be reviewed.

Ethics/Institutional Review Board Approval of Research
Authors should submit a statement from the research ethics committee or institutional review board indicating approval of the research. If the study was not submitted to a research ethics committee or institutional review board, authors need to provide documentation to prove that not seeking review for the study was in accordance with the policy of your institution.

Accessing the Abstract Submission Site

• To access the submission site, you should visit https://augsiuga.secure-platform.com:443/a/solicitations/63/home
• There are no restrictions on the number of submissions you may submit or on the number of submissions you may present.
• The deadline for electronic submissions for abstracts is January 31, 2022 at 11:59 PM, ET.
  
  

Submission Criteria

The following are the guidelines for all oral, poster, or video abstract submissions:

Language
Your abstract must be prepared in English

Abstract Character Limit

• Title character limit: None
• Body character limit: There is a limit of 500 words for the text of your submission.
• Figures and Tables limit: You may add up to 3 figures and/or tables to your submission. Figures and tables will appear at the end of your abstract, both on the proof and for publication. Figures and tables cannot be placed within the text of the submission.

Abstract Title

• Please make sure you double-check your title, as it will be published as submitted.
• Use mixed case for title – do not use all caps or all lowercase. Do not put your title in quotation marks.
• Titles do not have a character limit.
• Do not include trial group name in title of abstract.

Authors 

• Please consult with your co-authors on how they would like their names to appear. Please enter all authors in the order they should appear in the heading of the abstract. Please note you need to add all email addresses of the co-authors as well.
• All authors and co-authors must disclose any relevant financial relationship(s) at the time of submission.

Responsibilities of the Corresponding Author

The corresponding author is the primary contact for all correspondence regarding the abstract.

The corresponding author is responsible for the following:

• Ensuring that all authors have read the abstract and agreed to be co-authors.
• Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by AUGS/IUGA.
• Obtaining all the conflict of interest disclosure

Abstract Body

Omit all names and geographical references in the body of the abstract. Organize content in sections as follows:

• Introduction: Describe the background supporting the relevance of the research question
• Objective: State the purpose of the study or investigation.
• Methods: State details on study subjects, techniques, and/or observational/analytical methods.
• Results: Include your main findings, noting statistically significant data.
• Conclusions: Summarize principal conclusions, emphasizing new and important aspects

Disclosure

Disclose any 'relevant' financial relationships in accordance with the ACCME guidelines. The ACCME defines 'relevant' financial relationships as financial relationships in any amount occurring within the past 24 months that create a conflict of interest. List any financial interests, assistance, or relationships with companies, supporters, or commercial products related to the research (for example, ownership or partnership; research support; research grants; sponsors; stockholders, etc.). All listed authors/co-authors must complete a disclosure via the online abstract management system.

Product Name Usage

• For purposes of blind scoring, institutional names must be omitted whenever possible in the title and body of the abstract.
• Authors are requested to avoid the use of commercially branded names.
• If a specific device is only identifiable by its trade name, then this should appear in brackets after a generic description of the device.
• Should it be necessary to use a trade name, then the trade names of all similar products or those within a class must be used.

Revisions

• You may return to the online submission site to revise your abstract until January 31, 2022, at 11:59 PM, ET.
• After this date/time, the submission site will close, and no additional changes/edits can be made.
• If your abstract contains errors, you may opt to withdraw the abstract by sending an email to [email protected].
• If you have not completed all required sections, you will not be able to submit.

Withdrawals

• After January 31, presenting authors may submit a request to have an abstract withdrawn.
• To withdraw a submitted abstract, written notification must be sent to [email protected].
• This notification must include the title, authors and affiliations (as submitted), the abstract ID, and the name, affiliation, phone, fax and e‐mail of the submitter.
• In order for an accepted abstract to be withdrawn and not appear in publications, notification must be received by April 20, 2022.
• After this date, withdrawals are still accepted but abstracts may still appear in annual meeting materials.

Abstract Review

• After the submission site closes, completed abstracts will be peer reviewed.
• All abstracts will be blinded for review, meaning the abstracts will be reviewed without knowledge of the author/s, institution/s or disclosure information.
• Accepted abstracts will be selected as oral, oral poster, video or poster.

Abstract Acceptance/Rejection Notifications

• You will be notified electronically of the acceptance/rejection of your abstract in the beginning of March 2022.
• This notification will include the date and time of session/presentation as well as type of presentation if accepted.
• Only the corresponding author will be notified. It is the responsibility of the corresponding author to notify all co-authors.
  
  

Video Submission Guidelines 

The below criteria must be met for acceptance of video presentation.  

• Maximum duration: 8 minutes
• File cannot be above the 500 MB
• Videos must have English captions or narration
• Please ensure that your videos protect patient anonymity and integrity
• The preferred resolution is 1280x720p (16:9 aspect ratio) HD video
• Acceptable file formats are mp4, avi and mpeg4

PLEASE REMOVE ALL PRODUCT LOGOS/NAMES FROM VIDEO ‐ if a video is submitted with the product name/logo included, the video will be disqualified from consideration.

Embargo Policy

All accepted abstracts submitted to the AUGS/IUGA Scientific Meeting 2022 are embargoed until the first day of the meeting. The first author is responsible for conveying this information to all co-authors.

Content Validity and Fair Balance

Authors are required to prepare fair and balanced presentations that are objective and scientifically rigorous. All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.

Use of Generic Versus Trade Names 

Abstracts must use scientific or generic names when referring to products.

Awards

Accepted abstracts will be considered for the below awards.

• Best Clinical/Non-Surgical Abstract/Paper
• Best Clinical/Surgical Abstract/Paper
• Best Basic Science Abstract/Paper
• Base Quality of Life Abstract/Paper
• Best Epidemiology Abstract/Paper
• Best Podium presentation by fellow
• Best Video Award

注册费：

In-Person

Guest Registration

Guest Registration includes access to the Welcome Reception, Thursday Happy Hour, and Friday Night Party. Guests registered at the full rate must be 21 and over.

Industry Representatives

In-Person registration rates include online access to live-streamed and on-demand sessions. All live-streamed sessions will be recorded and be made available to in-person registrants for six months following the completion of the live meeting. 

Virtual*

*Virtual registration rates include access to live-streamed and on-demand sessions. All live-streamed sessions will be recorded and be made available to virtual AND in-person registrants for six months following the completion of the live meeting.

What will not be included:

• Surgical Tutorials
• Workshops
• Meet the Expert sessions
• Scientific Salons
• Regional Symposia
• Special Interest Group Meetings
• Fellow’s Didactics will only be open for Fellow’s

Additional Registration Options

Didactic Workshops

Hands-On Workshops

Basic Science Day

Regional Meeting Add-Ons

Additional Events

会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。